Zhangming N.

Zhangming N. is the Founder and CEO of MindRank AI, a clinical stage AI-powered drug discovery company established in March 2021. Prior experience includes serving as Chief Technology Officer at Aladdin Healthcare Technologies from March 2018 to February 2021, where strategic road maps and partnerships in Europe and the U.S. were developed. Zhangming also worked as Core Architect at Tradedoubler, contributing to significant e-commerce revenue in 2017, and as Product Owner for a data analytics platform at Ericsson, a leading telecommunications company. Additional experience includes software engineering roles at Genexis and Adeptic Technologies AB, and a graduation researcher position at Karolinska Institutet, where a high-performance distributed data platform was designed. Zhangming holds a Doctor of Philosophy in Clinical Medicine from Imperial College London, a Master’s degree in Computer Science from Chalmers University of Technology, and a Bachelor’s degree in Software Engineering from Jilin University.